Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GART is a trifunctional enzyme essential for the de novo biosynthesis of purines, catalyzing three sequential reactions in the pathway that leads to inosine monophosphate (IMP). It functions as Phosphoribosylamine–glycine ligase (GARS), Phosphoribosylglycinamide formyltransferase (GAR transformylase), and AIR synthetase (AIRS). Inhibition of GART is explored as a target for anticancer therapies due to its role in cell proliferation.
Inhibition of GART enzymatic activities, disruption of purine nucleotide biosynthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trifunctional purine biosynthetic protein adenosine–3 (GART).